PAMS
TARO

Pictet Asset Management (Switzerland)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,082
Closed -$220K – 1707
2022
Q1 		$220K Hold
5,082
– – ﹤0.01% 1519
2021
Q4 		$255K Hold
5,082
– – ﹤0.01% 1484
2021
Q3 		$323K Buy
+5,082
New +$352K ﹤0.01% 1372

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TARO Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2022, closing a stake of 5,082 shares — an estimated $220K sold.

Pictet Asset Management (Switzerland) first reported a position in TARO in Q3 2021 and held it in 3 quarters. The position peaked at $323K in Q3 2021. 72 funds tracked by Wall St. Rank hold TARO as of Q2 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 5,082 Taro Pharmaceutical Industries Ltd. shares in Q2 2022, an estimated $220K.
  • Pictet Asset Management (Switzerland) first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2021 and held it in 3 quarters.
  • Pictet Asset Management (Switzerland)'s Taro Pharmaceutical Industries Ltd. position peaked at $323K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.